Collectively, the diverse sub-populations, particularly the immunosuppressive <i>SPP1</i> <sup>+</sup> macrophages regulated immune suppression status within tumor microenvironment and represented a potential therapeutic target for DLBCL patients. Here, SPP1 is linked to neoplasm.